Evidence map›Paper›PMID 30744615›Full record

ArticleBMC biotechnology2019

Production of high titer of citric acid from inulin.

Magdalena Rakicka, Jakub Wolniak, Zbigniew Lazar, Waldemar Rymowicz

Open access · goldAbstract read
In one paragraph

Article in BMC biotechnology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Application of NewInternational journal of molecular sciences · 2024
    Article
  5. Review
  6. Article
  7. Metabolic engineering ofSynthetic and systems biotechnology · 2023
    Article
  8. Article
  9. Molecules (Basel, Switzerland) · 2022
    Review
  10. Review
  11. Article
  12. EngineeringMicroorganisms · 2020
    Article
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Magdalena RakickaDepartment of Biotechnology and Food Microbiology, Wroclaw University of Environmental and Life Sciences, 37 Chełmońskiego St, 51-630, Wroclaw, Poland. magdalena.rakicka@upwr.edu.pl.
Jakub WolniakDepartment of Biotechnology and Food Microbiology, Wroclaw University of Environmental and Life Sciences, 37 Chełmońskiego St, 51-630, Wroclaw, Poland.
Zbigniew LazarDepartment of Biotechnology and Food Microbiology, Wroclaw University of Environmental and Life Sciences, 37 Chełmońskiego St, 51-630, Wroclaw, Poland.
Waldemar RymowiczDepartment of Biotechnology and Food Microbiology, Wroclaw University of Environmental and Life Sciences, 37 Chełmońskiego St, 51-630, Wroclaw, Poland.
Wroclaw University of Environmental and Life Sciences · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCitric acid is considered as the most economically feasible product of microbiological production, therefore studies on cheap and renewable raw materials for its production are highly desirable. In this study citric acid was synthesized by genetically engineered strains of Yarrowia lipolytica from widely available, renewable polysaccharide - inulin. Hydrolysis of inulin by the Y. lipolytica strains was established by expressing the inulinase gene (INU1 gene; GenBank: X57202.1) with its native secretion signal sequence was amplified from genomic DNA from Kluyveromyces marxianus CBS6432. To ensure the maximum citric acid titer, the optimal cultivation strategy-repeated-batch culture was applied.

resultsThe strain Y. lipolytica AWG7 INU 8 secreted more than 200 g dm

conclusionsThe citric acid titer obtained in the proposed process is the highest value reported in the literature for Yarrowia yeast. The obtained results suggest that citric acid production from inulin by engineered Y. lipolytica may be a very promising technology for industrial citric acid production.

Indexed as

Genetic EngineeringBatch Cell Culture TechniquesBioreactorsCitric AcidGlycoside HydrolasesHydrolysisIndustrial MicrobiologyInulinKluyveromycesYarrowiaCitric AcidGlycoside HydrolasesInulininulinaseCitric acidInulinRepeated-batch cultureYarrowia lipolytica

Identifiers

PMID30744615
PMCPMC6371587
OpenAlexW2942835310

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.